Acadian Asset Management
ANIX icon

Acadian Asset Management’s Anixa Biosciences ANIX Stock Holding History

Acadian Asset Management’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33K Sell
12,898
-31,403
-71% -$93K ﹤0.01% 1899
2025
Q4 		$136K Buy
44,301
+23,526
+113% +$96.3K ﹤0.01% 1607
2025
Q3 		$66K Buy
+20,775
New +$65.7K ﹤0.01% 1600
2022
Q3 		– Sell
-8,675
Closed -$27K – 1663
2022
Q2 		$27K Buy
+8,675
New +$27.4K ﹤0.01% 1581

Other funds holding ANIX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Acadian Asset Management's ANIX Position: Q1 2026 in Review

Acadian Asset Management reduced its Anixa Biosciences (ANIX) stake by 71% in Q1 2026, selling an estimated $93K and leaving 12,898 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #1899.

Acadian Asset Management first reported a position in ANIX in Q2 2022 and has held it in 4 quarters since. The position peaked at $136K in Q4 2025. 60 funds tracked by Wall St. Rank hold ANIX as of Q1 2026.

  • Acadian Asset Management held 12,898 shares of Anixa Biosciences worth $33K as of Q1 2026.
  • Acadian Asset Management sold 31,403 Anixa Biosciences shares in Q1 2026, an estimated $93K.
  • Anixa Biosciences made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1899 holding.
  • Acadian Asset Management first reported a position in Anixa Biosciences in Q2 2022 and has held it in 4 quarters since.
  • Acadian Asset Management's Anixa Biosciences position peaked at $136K in Q4 2025.
  • 60 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.